Safety and Single-Dose Pharmacokinetics of Abacavir (1592U89) in Human Immunodeficiency Virus Type 1-Infected ChildrenW. William Hughes, Seth Hetherington, Mark W. Kline et al.|Antimicrobial Agents and Chemotherapy|1999Cited by 50
A Phase I Study of Abacavir (1592U89) Alone and in Combination With Other Antiretroviral Agents in Infants and Children With Human Immunodeficiency Virus InfectionMark W. Kline, Seth Hetherington, Suzette Blanchard et al.|PEDIATRICS|1999Cited by 41